To characterize gene expression differences in the response to TOPO, we first performed transcriptome profiling of a panel of PCa cell lines representing androgen-sensitive/resistant, androgen receptor +/-, and those of different ethnicities. The gene discussed is AR; the disease is posterior cortical atrophy.